UMBRALISIB for Follicular lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 48 adverse event reports in the FDA FAERS database where UMBRALISIB was used for Follicular lymphoma.
Most Reported Side Effects for UMBRALISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 47 | 16.0% | 2 | 5 |
| Nausea | 36 | 12.3% | 1 | 5 |
| Disease progression | 30 | 10.2% | 2 | 3 |
| Fatigue | 30 | 10.2% | 1 | 0 |
| Covid-19 | 16 | 5.5% | 3 | 13 |
| Nervous system disorder | 15 | 5.1% | 0 | 0 |
| Death | 14 | 4.8% | 14 | 4 |
| Asthenia | 13 | 4.4% | 1 | 2 |
| Off label use | 13 | 4.4% | 1 | 0 |
| Product dose omission issue | 12 | 4.1% | 0 | 3 |
| Anaemia | 11 | 3.8% | 0 | 0 |
| Decreased appetite | 11 | 3.8% | 1 | 2 |
| Pyrexia | 11 | 3.8% | 0 | 0 |
| Dizziness | 10 | 3.4% | 0 | 3 |
| Drug ineffective | 10 | 3.4% | 0 | 0 |
Other Indications for UMBRALISIB
Chronic lymphocytic leukaemia (66)
Non-hodgkin's lymphoma (50)
Product used for unknown indication (42)
Diffuse large b-cell lymphoma (20)
Marginal zone lymphoma (20)
B-cell lymphoma (18)
Lymphoma (9)
Other Drugs Used for Follicular lymphoma
LENALIDOMIDE (3,611)
RITUXIMAB (3,294)
OBINUTUZUMAB (2,527)
BENDAMUSTINE (1,560)
CYCLOPHOSPHAMIDE (1,367)
VINCRISTINE (1,224)
DOXORUBICIN (1,115)
PREDNISONE (889)
TAZEMETOSTAT HYDROBROMIDE (439)
ETOPOSIDE (352)